Patents by Inventor Joseph P. Kennedy

Joseph P. Kennedy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10889712
    Abstract: A thermoplastic elastomeric network is taught. The thermoplastic elastomer network includes hyperbranched styrenic block copolymers and styrenic block copolymers physically crosslinked though aggregation. Additionally, the hyperbranched styrenic block copolymers of the thermoplastic elastomeric network are a plurality of styrenic block copolymers chemically crosslinked.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: January 12, 2021
    Assignee: THE UNIVERSITY OF AKRON
    Inventors: Joseph P. Kennedy, Turgut Nugay, Nihan Nugay
  • Patent number: 10874673
    Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: December 29, 2020
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Paul S. Charifson, Michael P. Clark, Upul K. Bandarage, Randy S. Bethiel, John J. Court, Hongbo Deng, Ioana Davies, John P. Duffy, Luc J. Farmer, Huai Gao, Wenxin Gu, Dylan H. Jacobs, Joseph M. Kennedy, Mark W. Ledeboer, Brian Ledford, Francois Maltais, Emanuele Perola, Tiansheng Wang, M. Woods Wannamaker, Randal Byrn, Yi Zhou, Chao Lin, Min Jiang, Steven Jones, Ursula A. Germann, Francesco G. Salituro, Ann Dak-Yee Kwong
  • Patent number: 10875855
    Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A compound is represented by Structural Formula (I) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (I) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
    Type: Grant
    Filed: January 16, 2018
    Date of Patent: December 29, 2020
    Assignee: Vertex Pharmaceuticals Incorporated
    Inventors: Paul S. Charifson, Michael P. Clark, Upul K. Bandarage, Randy S. Bethiel, Michael J. Boyd, Ioana Davies, Hongbo Deng, John P. Duffy, Luc J. Farmer, Huai Gao, Wenxin Gu, Joseph M. Kennedy, Brian Ledford, Mark W. Ledeboer, Francois Maltais, Emanuele Perola, Tiansheng Wang
  • Patent number: 10793661
    Abstract: A star block copolymer and a thermoplastic elastomer including plurality of the star block copolymers and a method of making both is taught. The star block copolymers of the present invention include a core component having either a styrene oligomer or ?-methyl styrene oligomer, wherein arms emanate from the core component and the arms are poly(isobutylene-block-styrene) diblock copolymers.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: October 6, 2020
    Assignee: THE UNIVERSITY OF AKRON
    Inventors: Joseph P. Kennedy, Turgut Nugay, Nihan Nugay
  • Patent number: 10774185
    Abstract: In various embodiments, the present invention is directed to a centrally-functionalizable living cationic polymer or copolymer having a centrally-substituted tetraene group having the formula wherein each R is selected from the group consisting of a polymer or a copolymer, such as a polyisobutylene polymer or a poly(isobutylene-b-styrene) copolymer.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: September 15, 2020
    Assignee: The University of Akron
    Inventors: Joseph P. Kennedy, Turgut Nugay, Nihan Nugay, Tejal J. Deodhar, Susan Dollinger
  • Publication number: 20200278452
    Abstract: A system and method for estimating the position of a receiver and/or timing information for a receiver based on emissions from radio signal sources meant for applications other than position/navigation/time (PNT) estimation.
    Type: Application
    Filed: September 27, 2019
    Publication date: September 3, 2020
    Applicant: Echo Ridge LLC
    Inventors: JOSEPH P. KENNEDY, John P. Carlson, Martin Alles
  • Publication number: 20200247935
    Abstract: A star block copolymer and a thermoplastic elastomer including plurality of the star block copolymers and a method of making both is taught. The star block copolymers of the present invention include a core component having either a styrene oligomer or ?-methyl styrene oligomer, wherein arms emanate from the core component and the arms are poly(isobutylene-block-styrene) diblock copolymers.
    Type: Application
    Filed: April 21, 2020
    Publication date: August 6, 2020
    Applicant: THE UNIVERSITY OF AKRON
    Inventors: Joseph P. KENNEDY, Turgut NUGAY, Nihan NUGAY
  • Publication number: 20200109130
    Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Application
    Filed: October 16, 2019
    Publication date: April 9, 2020
    Inventors: Paul S. Charifson, Kevin Michael Cottrell, Hongbo Deng, John P. Duffy, Huai Gao, Simon Giroux, Jeremy Green, Katrina Lee Jackson, Joseph M. Kennedy, David J. Lauffer, Mark Willem Ledeboer, Pan Li, John Patrick Maxwell, Mark A. Morris, Albert Charles Pierce, Nathan D. Waal, Jinwang Xu
  • Publication number: 20200062732
    Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Application
    Filed: August 13, 2019
    Publication date: February 27, 2020
    Inventors: Paul S. Charifson, Kevin Michael Cottrell, Hongbo Deng, John P. Duffy, Huai Gao, Simon Giroux, Jeremy Green, Katrina Lee Jackson, Joseph M. Kennedy, David J. Lauffer, Mark Willem Ledeboer, Pan Li, John Patrick Maxwell, Mark A. Morris, Albert Charles Pierce, Nathan D. Waal, Jinwang Xu
  • Patent number: 10501439
    Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Grant
    Filed: March 5, 2018
    Date of Patent: December 10, 2019
    Assignee: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Paul S. Charifson, Kevin Michael Cottrell, Hongbo Deng, John P. Duffy, Huai Gao, Simon Giroux, Jeremy Green, Katrina Lee Jackson, Joseph M. Kennedy, David J. Lauffer, Mark Willem Ledeboer, Pan Li, John Patrick Maxwell, Mark A. Morris, Albert Charles Pierce, Nathan D. Waal, Jinwang Xu
  • Patent number: 10442791
    Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Grant
    Filed: January 2, 2018
    Date of Patent: October 15, 2019
    Assignee: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Paul S. Charifson, Kevin Michael Cottrell, Hongbo Deng, John P. Duffy, Huai Gao, Simon Giroux, Jeremy Green, Katrina Lee Jackson, Joseph M. Kennedy, David J. Lauffer, Mark Willem Ledeboer, Pan Li, John Patrick Maxwell, Mark A. Morris, Albert Charles Pierce, Nathan D. Waal, Jinwang Xu
  • Patent number: 10391095
    Abstract: The present invention relates to compounds useful as inhibitors of DNA-PK. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: August 27, 2019
    Assignee: VERTEX PHARMACEUTICALS INCORPORATED
    Inventors: Paul S. Charifson, Kevin Michael Cottrell, Hongbo Deng, John P. Duffy, Huai Gao, Simon Giroux, Jeremy Green, Katrina Lee Jackson, Joseph M. Kennedy, David J. Lauffer, Mark Willem Ledeboer, Pan Li, John Patrick Maxwell, Mark A. Morris, Albert Charles Pierce, Nathan D. Waal, Jinwang Xu
  • Publication number: 20190225757
    Abstract: In various embodiments, the present invention is directed to a centrally-functionalizable living cationic polymer or copolymer having a centrally-substituted tetraene group having the formula wherein each R is selected from the group consisting of a polymer or a copolymer, such as a polyisobutylene polymer or a poly(isobutylene-b-styrene) copolymer.
    Type: Application
    Filed: January 25, 2019
    Publication date: July 25, 2019
    Applicant: THE UNIVERSITY OF AKRON
    Inventors: JOSEPH P. KENNEDY, Turgut NUGAY, Nihan NUGAY, Tejal J. DEODHAR, Susan DOLLINGER
  • Patent number: 10329361
    Abstract: In one or more embodiments, the present invention provides a method for forming allyl telechelic polyisobutylene polymers having well defined molecular weights and molecular weight distributions using living cationic polymerization under ideal temperature control using a mixture of polar and nonpolar refluxing solvents. The methods according to various embodiments of the present invention provide temperature control that approaches the ideal, i.e., the heat of polymerization is instantaneously absorbed by the medium and the temperature of the system remains unchanged. The heat generated during the exothermic polymerization of isobutylene is released as an increase in the rate of reflux, rather than the temperature, since the temperature is set by the boiling point of the system and does not change.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: June 25, 2019
    Assignee: THE UNIVERSITY OF AKRON
    Inventors: Joseph P. Kennedy, Tejal J. Deodhar, Balazs L. Keszler
  • Publication number: 20190151314
    Abstract: Methods of inhibiting the replication of influenza viruses in a biological sample or patient, of reducing the amount of influenza viruses in a biological sample or patient, and of treating influenza in a patient, comprises administering to said biological sample or patient an effective amount of a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A compound is represented by Structural Formula (IA) or a pharmaceutically acceptable salt thereof, wherein the values of Structural Formula (IA) are as described herein. A pharmaceutical composition comprises an effective amount of such a compound or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, adjuvant or vehicle.
    Type: Application
    Filed: June 25, 2018
    Publication date: May 23, 2019
    Inventors: Paul S. Charifson, Michael P. Clark, Upul K. Bandarage, Randy S. Bethiel, John J. Court, Hongbo Deng, loana Davies, John P. Duffy, Luc J. Farmer, Huai Gao, Wenxin Gu, Dylan H. Jacobs, Joseph M. Kennedy, Mark W. Ledeboer, Brian Ledford, Francois Maltais, Emanuele Perola, Tiansheng Wang, M. Woods Wannamaker, Randal Byrn, Yi Zhou, Chao Lin, Min Jiang, Steven Jones, Ursula A. Germann, Francesco G. Salituro, Ann Dak-Yee Kwong
  • Patent number: 10280130
    Abstract: The present invention is directed to a new class of thermoplastic elastomers (TPEs) and processes for making them. In some embodiments of the present invention, the end groups of the multi-arm PIB copolymer is a conjugated diene, whereas the other component is a multi-functional dienophile. The components of the TPE of the present invention are chemically connected via the well-known Diels-Alder reaction which is thermally reversible (by the retro-Diels-Alder reaction) at moderately elevated temperatures. The reversibility of the Diels-Alder retro-Diels-Alder reactions allows the recovery of the original components of the TPE and thus its recyclability and also gives the TPE the ability to be reshaped or reformed.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: May 7, 2019
    Assignee: THE UNIVERSITY OF AKRON
    Inventors: Joseph P. Kennedy, Turgut Nugay, Nihan Nugay
  • Publication number: 20190092938
    Abstract: A thermoplastic elastomeric network is taught. The thermoplastic elastomer network includes hyperbranched styrenic block copolymers and styrenic block copolymers physically crosslinked though aggregation. Additionally, the hyperbranched styrenic block copolymers of the thermoplastic elastomeric network are a plurality of styrenic block copolymers chemically crosslinked.
    Type: Application
    Filed: September 18, 2018
    Publication date: March 28, 2019
    Applicant: THE UNIVERSITY OF AKRON
    Inventors: JOSEPH P. KENNEDY, Turgut NUGAY, Nihan NUGAY
  • Patent number: 10212687
    Abstract: A system and method to opportunistically capture and use measurements of barometric readings from a plurality of mobile agents to determine the elevational position of one of the mobile agents.
    Type: Grant
    Filed: September 24, 2015
    Date of Patent: February 19, 2019
    Assignee: Echo Ridge LLC
    Inventors: Joseph P. Kennedy, John P. Carlson
  • Publication number: 20180127524
    Abstract: In one or more embodiments, the present invention provides a method for forming allyl telechelic polyisobutylene polymers having well defined molecular weights and molecular weight distributions using living cationic polymerization under ideal temperature control using a mixture of polar and nonpolar refluxing solvents. The methods according to various embodiments of the present invention provide temperature control that approaches the ideal, i.e., the heat of polymerization is instantaneously absorbed by the medium and the temperature of the system remains unchanged. The heat generated during the exothermic polymerization of isobutylene is released as an increase in the rate of reflux, rather than the temperature, since the temperature is set by the boiling point of the system and does not change.
    Type: Application
    Filed: October 27, 2017
    Publication date: May 10, 2018
    Applicant: The University of Akron
    Inventors: Joseph P. Kennedy, Tejal J. Deodhar, Balazs L. Keszler
  • Patent number: 9967762
    Abstract: A system and method for evaluating the interactivity of RF devices in a virtual RF environment having selective virtual spectrum users remotely controlled by a web browser, where the virtual spectrum users have selectable interactivity parameters, and the virtual RF spectrum can be selectively changed, and the performance of the virtual spectrum users is evaluated and assigned scores as a function of the evaluation to determine which virtual spectrum user receives the highest amount of points.
    Type: Grant
    Filed: October 18, 2016
    Date of Patent: May 8, 2018
    Assignee: Echo Ridge LLC
    Inventors: Joseph P. Kennedy, Sharif Shaher